Beneath the Copper—Pediatric Wilson's Disease Cirrhosis and Hepatocellular Carcinoma: A Case Report with Literature Review

Abstract

Primary hepatic malignancies are uncommon in pediatrics. Tumors such as hepatocellular carcinoma (HCC) develop typically in the setting of chronic liver disease. The incidence of HCC in Wilson's disease-related cirrhosis is disproportionately lower than in many other forms of end-stage liver disease. A preadolescent girl presented with Wilson's disease cirrhosis and a HCC requiring orthotopic liver transplantation. This case highlights the need to consider hepatic malignancies even in young Wilson's disease patients. Pediatric Wilson's disease and the hepatic tumor literature are reviewed.

Keywords

Wilson's disease - hepatocellular carcinoma - pediatrics - liver transplantation

• References

• 1 Ferenci P, Caca K, Loudianos G , et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003; 23 (3) 139-142
• 2 Wanless IR, Callea F, Craig JR , et al; International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22 (3) 983-993
• 3 Meyers RL. Tumors of the liver in children. Surg Oncol 2007; 16 (3) 195-203
• 4 Stocker JT. Hepatic tumors in children. Clin Liver Dis 2001; 5 (1) 259-281 , viii–ix
• 5 Czauderna P, Mackinlay G, Perilongo G , et al; Liver Tumors Study Group of the International Society of Pediatric Oncology. Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group. J Clin Oncol 2002; 20 (12) 2798-2804
• 6 Ala A, Schilsky ML. Wilson disease: pathophysiology, diagnosis, treatment, and screening. Clin Liver Dis 2004; 8 (4) 787-805 , viii
• 7 Thomas GR, Roberts EA, Walshe JM, Cox DW. Haplotypes and mutations in Wilson disease. Am J Hum Genet 1995; 56 (6) 1315-1319
• 8 Human Genome Mutation Database Available at: http://www.hgmd.cf.ac.uk/ac/index.php . Accessed February 5, 2015
• 9 Luoma LM, Deeb TMM, Macintyre G, Cox DW. Functional analysis of mutations in the ATP loop of the Wilson disease copper transporter, ATP7B. Hum Mutat 2010; 31 (5) 569-577
• 10 Kenney SM, Cox DW. Sequence variation database for the Wilson disease copper transporter, ATP7B. Hum Mutat 2007; 28 (12) 1171-1177
• 11 Ferenci P. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing. Hum Genet 2006; 120 (2) 151-159
• 12 Ye S, Gong L, Shui QX, Zhou LF. Wilson disease: identification of two novel mutations and clinical correlation in Eastern Chinese patients. World J Gastroenterol 2007; 13 (38) 5147-5150
• 13 Mukherjee S, Dutta S, Majumdar S , et al. Genetic defects in Indian Wilson disease patients and genotype-phenotype correlation. Parkinsonism Relat Disord 2014; 20 (1) 75-81
• 14 Beinhardt S, Leiss W, Stättermayer AF , et al. Long-term outcomes of patients with Wilson disease in a large Austrian cohort. Clin Gastroenterol Hepatol 2014; 12 (4) 683-689
• 15 Arnon R, Annunziato R, Schilsky M , et al. Liver transplantation for children with Wilson disease: comparison of outcomes between children and adults. Clin Transplant 2011; 25 (1) E52-E60
• 16 Cheng F, Li GQ, Zhang F , et al. Outcomes of living-related liver transplantation for Wilson's disease: a single-center experience in China. Transplantation 2009; 87 (5) 751-757
• 17 Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med 1995; 18 (2) 321-336
• 18 Asare GA, Mossanda KS, Kew MC, Paterson AC, Kahler-Venter CP, Siziba K. Hepatocellular carcinoma caused by iron overload: a possible mechanism of direct hepatocarcinogenicity. Toxicology 2006; 219 (1–3) 41-52
• 19 Jüngst C, Cheng B, Gehrke R , et al. Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma. Hepatology 2004; 39 (6) 1663-1672
• 20 Elmberg M, Hultcrantz R, Ekbom A , et al. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastroenterology 2003; 125 (6) 1733-1741
• 21 Sokol RJ, Twedt D, McKim Jr JM , et al. Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. Gastroenterology 1994; 107 (6) 1788-1798
• 22 Mori M, Hattori A, Sawaki M , et al. The LEC rat: a model for human hepatitis, liver cancer, and much more. Am J Pathol 1994; 144 (1) 200-204
• 23 Karmahapatra SK, Saha T, Adhikari S, Woodrick J, Roy R. Redox regulation of apurinic/apyrimidinic endonuclease 1 activity in Long-Evans Cinnamon rats during spontaneous hepatitis. Mol Cell Biochem 2014; 388 (1–2) 185-193
• 24 Kato J, Kobune M, Kohgo Y , et al. Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in Long-Evans Cinnamon rats. J Clin Invest 1996; 98 (4) 923-929
• 25 Walshe JM, Waldenström E, Sams V, Nordlinder H, Westermark K. Abdominal malignancies in patients with Wilson's disease. QJM 2003; 96 (9) 657-662
• 26 Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut 2007; 56 (1) 115-120
• 27 Bruha R, Marecek Z, Pospisilova L , et al. Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation. Liver Int 2011; 31 (1) 83-91
• 28 Członkowska A, Tarnacka B, Litwin T, Gajda J, Rodo M. Wilson's disease-cause of mortality in 164 patients during 1992–2003 observation period. J Neurol 2005; 252 (6) 698-703
• 29 Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004; 127 (5) (Suppl. 01) S35-S50
• 30 Theocharis SE, Margeli AP, Klijanienko JT, Kouraklis GP. Metallothionein expression in human neoplasia. Histopathology 2004; 45 (2) 103-118
• 31 Bremner I. Involvement of metallothionein in the hepatic metabolism of copper. J Nutr 1987; 117 (1) 19-29
• 32 Park Y, Yu E. Expression of metallothionein-1 and metallothionein-2 as a prognostic marker in hepatocellular carcinoma. J Gastroenterol Hepatol 2013; 28 (9) 1565-1572
• 33 Savas N, Canan O, Ozcay F , et al. Hepatocellular carcinoma in Wilson's disease: a rare association in childhood. Pediatr Transplant 2006; 10 (5) 639-643
• 34 Thattil R, Dufour JF. Hepatocellular carcinoma in a non-cirrhotic patient with Wilson's disease. World J Gastroenterol 2013; 19 (13) 2110-2113
• 35 Nicastro E, Ranucci G, Vajro P, Vegnente A, Iorio R. Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease. Hepatology 2010; 52 (6) 1948-1956
• 36 Wilson DC, Phillips MJ, Cox DW, Roberts EA. Severe hepatic Wilson's disease in preschool-aged children. J Pediatr 2000; 137 (5) 719-722
• 37 Walia BNS, Singh S, Marwaha RK, Bhusnurmath SR, Dilawari JB. Fulminant hepatic failure and acute intravascular haemolysis as presenting manifestations of Wilson's disease in young children. J Gastroenterol Hepatol 1992; 7 (4) 370-373
• 38 Thoreau HD. A Week on the Concord and Merrimack Rivers (New and Revised Ed.). Boston, MA: James R. Osgood and Company; 1873: 155